Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
1951
DELISTED
Mersana Therapeutics
MRSN
| $2.01M | ﹤0.01% |
34,629
-2,408
| -7% | -$96.9K |
|
1952
Ceco Environmental
CECO
$4.04B
| $2M | ﹤0.01% |
98,783
-13,000
| -12% | -$237K |
|
1953
Cimpress
CMPR
$2.44B
| $2M | ﹤0.01% |
25,000
+6,400
| +34% | +$446K |
|
1954
Air T
AIRT
$86.1M
| $1.99M | ﹤0.01% |
118,011
-1,300
| -1% | -$26.2K |
|
1955
iShares MSCI Intl Value Factor ETF
IVLU
$4.5B
| $1.99M | ﹤0.01% |
+75,000
| New | +$1.91M |
|
1956
MediaAlpha
MAX
$755M
| $1.99M | ﹤0.01% |
178,100
+12,900
| +8% | +$128K |
|
1957
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
| $1.98M | ﹤0.01% |
+28,722
| New | +$1.87M |
|
1958
Hooker Furnishings Corp
HOFT
$159M
| $1.98M | ﹤0.01% |
76,000
-2,600
| -3% | -$51.9K |
|
1959
Vitesse Energy
VTS
$659M
| $1.96M | ﹤0.01% |
89,300
-60,595
| -40% | -$1.4M |
|
1960
iShares MSCI Germany ETF
EWG
$1.61B
| $1.95M | ﹤0.01% |
+65,700
| New | +$1.79M |
|
1961
Espey Mfg & Electronics Corp
ESP
$184M
| $1.94M | ﹤0.01% |
103,831
+4,219
| +4% | +$71.7K |
|
1962
Taysha Gene Therapies
TSHA
$1.86B
| $1.94M | ﹤0.01% |
1,097,400
+499,400
| +84% | +$996K |
|
1963
Grupo Aval
AVAL
$6.29B
| $1.94M | ﹤0.01% |
797,493
+47,321
| +6% | +$108K |
|
|
HTBK
1964
DELISTED
Heritage Commerce
HTBK
| $1.93M | ﹤0.01% |
194,900
+45,273
| +30% | +$399K |
|
|
VPU
1965
Vanguard Utilities ETF
VPU
$8.35B
| $1.93M | ﹤0.01% |
+14,100
| New | +$1.86M |
|
|
KAMN
1966
DELISTED
Kaman Corp
KAMN
| $1.93M | ﹤0.01% |
80,722
-1,382
| -2% | -$28.6K |
|
|
SEI
1967
Solaris Energy Infrastructure
SEI
$3.41B
| $1.93M | ﹤0.01% |
242,700
+153,500
| +172% | +$1.39M |
|
1968
Avantis US Small Cap Value ETF
AVUV
$30.9B
| $1.93M | ﹤0.01% |
21,500
+8,200
| +62% | +$656K |
|
1969
First Hawaiian
FHB
$3.38B
| $1.93M | ﹤0.01% |
84,300
-104,488
| -55% | -$2.04M |
|
1970
DMC Global
BOOM
$150M
| $1.93M | ﹤0.01% |
102,268
+5,300
| +5% | +$97.4K |
|
|
GTHX
1971
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.92M | ﹤0.01% |
630,400
+156,320
| +33% | +$294K |
|
1972
Acco Brands
ACCO
$402M
| $1.92M | ﹤0.01% |
315,600
-78,800
| -20% | -$418K |
|
1973
AmeriServ Financial
ASRV
$78.4M
| $1.92M | ﹤0.01% |
593,184
-9,545
| -2% | -$26.4K |
|
|
MDRX
1974
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.92M | ﹤0.01% |
182,665
+1,100
| +0.6% | +$13.5K |
|
1975
HNI Corp
HNI
$3.5B
| $1.91M | ﹤0.01% |
45,746
-92,266
| -67% | -$3.51M |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.